Wall Street Zen upgraded shares of NervGen Pharma (NASDAQ:NGEN – Free Report) from a strong sell rating to a sell rating in a research note released on Saturday,Wall Street Zen reports. A number of other research firms have also recently commented on NGEN. Leerink Partners began coverage on NervGen Pharma in a research report on […]

Athira Pharma (NASDAQ:LONA – Get Free Report) was upgraded by Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports. A number of other research firms have also commented on LONA. Mizuho dropped their price objective on Athira Pharma from $16.00 to $15.00 and set […]

Forafric Global (NASDAQ:AFRI – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a research note issued on Saturday, Wall Street Zen reports. Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Forafric Global in a research note on Thursday, August 13th. One research analyst […]

Wall Street Zen downgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday morning,Wall Street Zen reports. A number of other research analysts have also weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares […]